13h
Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook
Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical ...
Zacks Investment Research on MSN
Will AbbVie's oncology drugs aid top line in 2026?
AbbVie ABBV has built a significant presence in the oncology space. While the majority of the revenues are generated from ...
Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in ...
Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results